National Cancer Institute - Cancer.gov

Daniel Armstrong

Primary Position
Professor & Executive Vice Chair, Department of Pediatrics; Director, Mailman Center for Child Development and Director, University of Miami Sickle Cell Center, University of Miami Miller School of Medicine
Job Responsibilities
Research
Patient Care
Other
Other Job Responsibilities
Leadership, Administration
Education/Training
Psychology
Short Synopsis of Professional Interests
My research focuses on neurodevelopmental outcomes of childhood cancer, sickle cell disease, and HIV.
Training Opportunities at Location
Yes
P.O. Box 016820 (D-820)
Miami, FL 33101
eMAIL
darmstrong@miami.edu
Phone(s)
305-243-6801
Keywords
Neurocognitive outcomes
childhood cancer
sickle cell disease
health disparities
translation research
Publications of Interest

Armstrong, F.D. (2013). Invited Editorial: Implications of 25-Year Follow-up of White Matter Integrity and Neurocognitive Function of Childhood Leukemia Survivors: A Wake-up Call. Journal of Clinical
Oncology, 31(27), 3309-3311. Published ahead of print on August 19, 2013.

Armstrong,F.D. (2012). Invited Editorial: Proton-Beam Radiation Therapy and Health-Related Quality of Life in Children with Central Nervous System Tumors. Journal of Clinical Oncology, 30(17), 2028-2029. Published ahead of print on May 7, 2012.
 

Duffner, P.K., Armstrong, F.D., Chen, L., Helton, K., Brecher, M.L., Bell, B., & Chauvenet , A.R. (2014). Neurocognitive and neuroradiologic central nervous system late effects in children with acute lymphoblastic leukemia treated on POG 9605 and 9201 (ACCL0131): A methotrexate
consequence? A report from the Children¹s Oncology Group. Journal of Pediatric Hematology Oncology, 31 (1), 8-15.

Ris, M.D., Walsh, K., Armstrong, F.D., Wallace, D., Holms, E., Gajjar, A., Zhou, T., & Packer, R. (2013). Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average risk medulloblastoma: COG A9961. Pediatric Blood and Cancer. (DOI
10.1002/pbc.24496). Published online February 26, 2013.

Armstrong, F.D. (February, 2014). Benefits of modified craniospinal radiation therapy for children treated for medulloblastoma: Preserving long-term neurocognitive function. Invited Podcast. Journal of Clinical
Oncology.